NasdaqGS - Nasdaq Real Time Price USD

Intra-Cellular Therapies, Inc. (ITCI)

Compare
94.87
+12.31
+(14.91%)
At close: January 10 at 4:00:02 PM EST
95.16
+0.29
+(0.31%)
After hours: January 10 at 5:21:55 PM EST
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
728,295.00
754,780.00
489,922.00
717,313.67
Total Liabilities Net Minority Interest
136,871.00
98,710.00
72,032.00
60,453.57
Total Equity Gross Minority Interest
591,424.00
656,070.00
417,890.00
656,860.10
Total Capitalization
591,424.00
656,070.00
417,890.00
656,860.10
Common Stock Equity
591,424.00
656,070.00
417,890.00
656,860.10
Capital Lease Obligations
16,938.00
20,041.00
25,407.00
29,142.15
Net Tangible Assets
591,424.00
656,070.00
417,890.00
656,860.10
Working Capital
544,254.00
654,721.00
413,924.00
654,051.26
Invested Capital
591,424.00
656,070.00
417,890.00
656,860.10
Tangible Book Value
591,424.00
656,070.00
417,890.00
656,860.10
Total Debt
16,938.00
20,041.00
25,407.00
29,142.15
Share Issued
96,379.81
94,829.79
81,886.97
80,463.09
Ordinary Shares Number
96,379.81
94,829.79
81,886.97
80,463.09
12/31/2020 - 1/7/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers